These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
834 related articles for article (PubMed ID: 9003010)
21. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10. Dey BR; Frick K; Lopaczynski W; Nissley SP; Furlanetto RW Mol Endocrinol; 1996 Jun; 10(6):631-41. PubMed ID: 8776723 [TBL] [Abstract][Full Text] [Related]
22. Pertussis toxin-sensitive and insensitive intracellular signalling pathways in undifferentiated 3T3-L1 cells stimulated by insulin converge with phosphatidylinositol 3-kinase upstream of the Ras mitogen-activated protein kinase cascade. Uehara T; Tokumitsu Y; Nomura Y Eur J Biochem; 1999 Feb; 259(3):801-8. PubMed ID: 10092867 [TBL] [Abstract][Full Text] [Related]
23. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes. Valverde AM; Lorenzo M; Pons S; White MF; Benito M Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931 [TBL] [Abstract][Full Text] [Related]
24. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking. Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245 [TBL] [Abstract][Full Text] [Related]
25. Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling. Ugi S; Imamura T; Ricketts W; Olefsky JM Mol Cell Biol; 2002 Apr; 22(7):2375-87. PubMed ID: 11884620 [TBL] [Abstract][Full Text] [Related]
27. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5. Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744 [TBL] [Abstract][Full Text] [Related]
28. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues. Thirone AC; Carvalho CR; Saad MJ Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807 [TBL] [Abstract][Full Text] [Related]
29. Augmented growth response to IGF-1 via increased IRS-1 in Chinese hamster ovary cells expressing kinase-negative insulin receptors. Inoue S; Fukuda K; Kudara T; Igura T; Inui Y; Tamura S; Hanafusa T; Kawata S; Matsuzawa Y Diabetologia; 1999 Jun; 42(6):763-72. PubMed ID: 10382598 [TBL] [Abstract][Full Text] [Related]
30. A comparison of epidermal growth factor receptor-mediated mitogenic signaling in response to transforming growth factor alpha and epidermal growth factor in cultured fetal rat hepatocytes. Lipeski LE; Boylan JM; Gruppuso PA Biochem Mol Biol Int; 1996 Aug; 39(5):975-83. PubMed ID: 8866014 [TBL] [Abstract][Full Text] [Related]
31. Growth factors differentially stimulate the phosphorylation of Shc proteins and their association with Grb2 in PC-12 pheochromocytoma cells. Ohmichi M; Matuoka K; Takenawa T; Saltiel AR J Biol Chem; 1994 Jan; 269(2):1143-8. PubMed ID: 8288573 [TBL] [Abstract][Full Text] [Related]
32. Gab2 tyrosine phosphorylation by a pleckstrin homology domain-independent mechanism: role in epidermal growth factor-induced mitogenesis. Kong M; Mounier C; Balbis A; Baquiran G; Posner BI Mol Endocrinol; 2003 May; 17(5):935-44. PubMed ID: 12595575 [TBL] [Abstract][Full Text] [Related]
33. Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor. Giorgetti S; Pelicci PG; Pelicci G; Van Obberghen E Eur J Biochem; 1994 Jul; 223(1):195-202. PubMed ID: 8033892 [TBL] [Abstract][Full Text] [Related]
34. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals. Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243 [TBL] [Abstract][Full Text] [Related]
35. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts. Conejo R; Lorenzo M J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354 [TBL] [Abstract][Full Text] [Related]
36. Fatty acid induced insulin resistance in rat-1 fibroblasts overexpressing human insulin receptors: impaired insulin-stimulated mitogen-activated protein kinase activity. Usui I; Takata Y; Imamura T; Morioka H; Sasaoka T; Sawa T; Ishihara H; Ishiki M; Kobayashi M Diabetologia; 1997 Aug; 40(8):894-901. PubMed ID: 9267983 [TBL] [Abstract][Full Text] [Related]
38. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin. Pruett W; Yuan Y; Rose E; Batzer AG; Harada N; Skolnik EY Mol Cell Biol; 1995 Mar; 15(3):1778-85. PubMed ID: 7862167 [TBL] [Abstract][Full Text] [Related]
39. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Chow JC; Ling PR; Qu Z; Laviola L; Ciccarone A; Bistrian BR; Smith RJ Endocrinology; 1996 Jul; 137(7):2880-6. PubMed ID: 8770909 [TBL] [Abstract][Full Text] [Related]
40. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway. Lassarre C; Ricort JM Endocrinology; 2003 Nov; 144(11):4811-9. PubMed ID: 12960057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]